What is the recommended imaging modality for evaluating fatty liver?

Recommended Imaging for Fatty Liver

Abdominal ultrasonography is the primary screening modality for fatty liver disease. 1

First-Line Imaging Approach

Use ultrasound as your initial imaging test because it provides the best balance of availability, cost, safety, and diagnostic utility for moderate-to-severe steatosis 1, 2. While ultrasound has limitations—including subjective interpretation, reduced sensitivity when steatosis is <20-30%, difficulty in obese patients, and inability to distinguish NASH from simple steatosis 1—it remains appropriate as a screening tool because it:

• Demonstrates robust diagnostic performance for moderate or severe steatosis
• Evaluates the entire hepatobiliary system beyond just detecting fat
• Is widely available and radiation-free 1

Important Caveats About Ultrasound

Do not use ultrasound for grading steatosis severity. The evidence clearly shows ultrasound lacks accuracy for grading—children with "mild steatosis" by ultrasound had moderate steatosis on biopsy in ~50% of cases, and those graded as "moderate" ranged from mild to severe on reference standards 3. This high misclassification rate makes ultrasound unreliable for disease monitoring or treatment response assessment.

Normal ultrasound does not exclude fatty liver, particularly when steatosis is mild (<20-30%) 1, 2.

When to Use Advanced Imaging

MRI-PDFF (Proton Density Fat Fraction)

MRI is the most accurate imaging tool for quantifying liver fat 1, 4, 5. Specifically:

• MRI-PDFF is the gold standard for fat quantification, offering superior accuracy to ultrasound and CT 1, 4
• Use MRI when precise quantification is needed, particularly for:
  • Clinical trials requiring accurate endpoints 2, 5
  • Monitoring treatment response where subtle changes matter 1
  • When ultrasound is technically limited (severe obesity, mild steatosis) 2

However, MRI is expensive and not recommended for routine clinical screening 2. Reserve it for situations where quantification genuinely changes management.

CT Imaging

CT has limited utility for fatty liver evaluation 1:

• Unenhanced CT can detect moderate-to-severe steatosis with high specificity (100%) but poor sensitivity (53.8%) 1
• Performance is suboptimal for mild steatosis 1
• Radiation exposure is a concern 1
• CT may have a role in opportunistic screening when performed for other indications 4, 6

Controlled Attenuation Parameter (CAP)

CAP via transient elastography can quantify liver fat and may be useful when available 1:

• Korean studies show AUCs of 0.885-0.894 for detecting steatosis grades 1
• Can be performed simultaneously with liver stiffness measurement for fibrosis assessment 1
• More data needed to fully define its role compared to ultrasound 2

Practical Clinical Algorithm

1. Start with ultrasound for initial detection in at-risk patients (diabetes, metabolic syndrome, elevated liver enzymes) 1

2. If ultrasound shows steatosis, proceed with:

   • Fibrosis risk stratification (FIB-4, NFS, or elastography)
   • Evaluation for metabolic comorbidities
   • Assessment for other liver disease causes

3. Consider MRI-PDFF when:

   • Ultrasound is technically inadequate
   • Precise quantification needed for clinical trials
   • Monitoring treatment response where small changes are clinically important
   • Differentiating between competing diagnoses

4. Do NOT use imaging alone to distinguish NASH from simple steatosis—this requires liver biopsy or clinical context 1, 2

Key Pitfall to Avoid

The most common error is over-relying on ultrasound grading of steatosis severity. Use ultrasound to detect the presence of fatty liver, but do not base clinical decisions on whether ultrasound reports "mild," "moderate," or "severe" steatosis—these grades are unreliable 3.